<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30163" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thyroiditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fariduddin</surname>
            <given-names>Maria M.</given-names>
          </name>
          <aff>MD at Home</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Gurdeep</given-names>
          </name>
          <aff>Our Lady of Lourdes Memorial Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Fariduddin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gurdeep Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30163.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>This activity reviews the different types of thyroiditis, their presentation, evaluation, diagnosis and treatment and highlights the role of the interprofessional team to work closely with endocrinology in recognizing the correct type of thyroiditis and instituting appropriate timely management of patients with this disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of different kinds of thyroiditis.</p></list-item><list-item><p>Review the appropriate evaluation of a patient presenting with signs and symptoms of thyroiditis.</p></list-item><list-item><p>Outline the management options available for various types of thyroiditis.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to manage thyroiditis and improve patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30163">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30163.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term thyroiditis reflects inflammation of the thyroid gland. Thyroiditis can be classified based on the onset of symptoms, underlying etiology, and clinical symptoms. The most common cause of thyroiditis is an autoimmune disease. In the United States, Hashimoto thyroiditis is the most common cause of hypothyroidism.<xref ref-type="bibr" rid="article-30163.r1">[1]</xref>&#x000a0;Thyroiditis can cause transient or permanent hypo and hyperthyroidism.</p>
      </sec>
      <sec id="article-30163.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Thyroiditis can occur due to autoimmune disease (Hashimoto thyroiditis, Graves disease, postpartum thyroiditis or painless sporadic thyroiditis), infection (painful subacute thyroiditis or suppurative thyroiditis), drugs (amiodarone, lithium, interferons and interleukin-2; and checkpoint inhibitors) or fibrosis (Riedel thyroiditis)</p>
        <p>Painful thyroiditis encompasses infectious, subacute thyroiditis, traumatic or radiation-induced thyroiditis, and painless thyroiditis encompass autoimmune, postpartum, and drug-induced thyroiditis.</p>
        <p>It can be classified into acute, subacute, and chronic thyroiditis.&#x000a0;</p>
        <p>Acute thyroiditis is caused by bacterial infection of the gland.</p>
        <p>Subacute, also known as granulomatous thyroiditis, is caused by viruses.</p>
        <p>Chronic includes autoimmune thyroiditis, Hashimoto thyroiditis, postpartum thyroiditis, and other painless thyroiditis, including iatrogenic and drug-induced thyroiditis.&#x000a0;</p>
        <p>
<bold>Acute Thyroiditis </bold>
</p>
        <p>Infectious thyroiditis: Infection of the thyroid gland is rare as it is encapsulated with rich blood supply and extensive lymphatic drainage. This is usually seen in the elderly, chronically ill and immunocompromised patients.<xref ref-type="bibr" rid="article-30163.r2">[2]</xref> It is most commonly caused by gram-positive bacteria like <italic toggle="yes">Staphylococcus </italic>or <italic toggle="yes">Streptococcus. S</italic>ometimes mycobacteria and fungi, including pneumocystis, can be the culprit in immunocompromised patients. Source of infection is usually hematogenous or congenital abnormalities like pyriform sinus usually seen in children.</p>
        <p>Radiation-induced thyroiditis: Radiation treatment of neck cancer can cause thyroiditis, followed by hypothyroidism. Patients who receive radioactive iodine for ablation of Graves disease occasionally develop severe thyroid pain 7 to 10 days after therapy. It is rare, and the incidence is about 1%.&#x000a0;</p>
        <p>
<bold>Subacute Thyroiditis</bold>
</p>
        <p>It is usually preceded by upper respiratory tract infections and is presumed to be due to a viral illness, though definite evidence is lacking.<xref ref-type="bibr" rid="article-30163.r3">[3]</xref> There is also a strong association with HLA -35.<xref ref-type="bibr" rid="article-30163.r4">[4]</xref></p>
        <p>
<bold>Chronic Thyroiditis</bold>
</p>
        <p>Autoimmune thyroiditis: It includes Hashimoto thyroiditis and postpartum thyroiditis and its association with HLA-DR3, HLA-DR4, HLA-DR5 has been reported in Whites.<xref ref-type="bibr" rid="article-30163.r5">[5]</xref><xref ref-type="bibr" rid="article-30163.r6">[6]</xref><xref ref-type="bibr" rid="article-30163.r7">[7]</xref> Hashimoto thyroiditis is the most common cause of hypothyroidism in the United States. It is presumed to be due to a viral infection, with the viral structure being similar to thyroid protein leading to the production of antibodies against the thyroid gland. Approximately 10% of the general population in the US has a high concentration of these antibodies, but the majority of them have normal thyroid function tests.<xref ref-type="bibr" rid="article-30163.r8">[8]</xref> However, there is a risk of progression to overt hypothyroidism in such individuals.</p>
        <p>Postpartum thyroiditis: It is an autoimmune phenomenon where antibodies formed against fetal thyroid cells accumulate in the mother's thyroid gland.<xref ref-type="bibr" rid="article-30163.r9">[9]</xref> It occurs in postpartum women within one year of childbirth. The maternal presence of positive thyroid peroxidase antibody or other autoimmune diseases is a risk factor.</p>
        <p>Drug-induced thyroiditis: The most common drugs causing thyroid dysfunction are amiodarone, lithium, and tyrosine kinase inhibitors.</p>
        <p>Amiodarone can cause both hyper and hypothyroidism. In euthyroid individuals, amiodarone can cause transient changes in thyroid function tests (TFT), followed by normalization. In patients who have underlying Hashimoto, or pregnant are at risk of developing worsening hypothyroidism. It is thought to be secondary to the antithyroid effect of the iodine in amiodarone. Amiodarone can induce hyperthyroidism in two ways. In type 1, there is increased synthesis and release of thyroid hormone, whereas, in type 2, there is destructive thyroiditis leading to the release of preformed T4 and T3 from the damaged thyroid gland.</p>
        <p>Checkpoint inhibitors are a type of immunotherapy with anti-neoplastic properties and include drugs like nivolumab, ipilimumab, pembrolizumab, and atezolizumab. They are associated with endocrinopathies especially, hypothyroidism secondary to destructive thyroiditis.<xref ref-type="bibr" rid="article-30163.r10">[10]</xref>&#x000a0;Patients usually present with vague symptoms of hypothyroidism like fatigue, weight gain. It should be distinguished from secondary hypothyroidism as these drugs also cause hypophysitis. Hyperthyroidism though very rare, is also seen.</p>
        <p>Lithium is known to cause hypothyroidism by decreasing the secretion of thyroid hormones. This causes a rise in TSH and eventually enlargement of the thyroid gland and goiter. About 15% of patients on interferon alfa therapy can develop thyroid dysfunction.<xref ref-type="bibr" rid="article-30163.r11">[11]</xref> Thyroid abnormalities, including both hyper and hypothyroidism, can be seen in patients on tyrosine kinase inhibitors, especially sunitinib and lenvatinib.</p>
        <p>Riedel thyroiditis: Reidel thyroiditis is a rare condition characterized by progressive fibrosis of the thyroid gland. The exact etiology is unclear, but recent data indicate that it is closely related to IgG-4 related sclerosing disease. The fibrosis of the thyroid gland may or may not be associated with progressive fibrosis of other organs.<xref ref-type="bibr" rid="article-30163.r12">[12]</xref></p>
      </sec>
      <sec id="article-30163.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Hashimoto thyroiditis is the most common cause of hypothyroidism, while Graves disease is the most common cause of autoimmune hyperthyroidism in the United States. High intake of iodine can increase the incidence of Graves disease, whereas iodine insufficiency can be protective against autoimmune thyroiditis.<xref ref-type="bibr" rid="article-30163.r13">[13]</xref></p>
      </sec>
      <sec id="article-30163.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Acute Thyroiditis</bold>
</p>
        <p>Infectious thyroiditis is caused by gram-positive bacteria like streptococcus, staphylococcus, or fungi, mycoparasitic infection.<xref ref-type="bibr" rid="article-30163.r2">[2]</xref></p>
        <p>The destruction of thyroid parenchyma causes radiation-induced thyroiditis after exposure to radioactive iodine for treatment of Graves disease or thyroid cancer and high dose radiation to the neck for the lymphoma and other head and neck cancers.</p>
        <p>
<bold>Subacute Thyroiditis</bold>
</p>
        <p>This is caused by viruses like coxsackie A, B, echovirus. Granulomas are formed in the thyroid gland, which becomes fibrotic but can return to normal after treatment.</p>
        <p>
<bold>Chronic Thyroiditis</bold>
</p>
        <p>Hashimoto thyroiditis is an autoimmune phenomenon characterized by lymphocytic infiltration of the gland presumed to be due to similarities between thyroid protein and the viral structure resulting in cross-reacting antibodies. Anti-TPO antibodies that are present in 90% of patients with Hashimoto thyroiditis fix complement and are hence capable of inducing antibody-dependent cell-mediated cytotoxicity, causing the death of thyrocytes.<xref ref-type="bibr" rid="article-30163.r14">[14]</xref></p>
        <p>Postpartum thyroiditis is a destructive thyroiditis characterized by lymphocytic infiltration of the thyroid gland. Fetal cells that migrate to the maternal thyroid gland tend to survive the immunocompromised pregnancy state, and when the maternal immune system rebounds postpartum, it activates the autoimmune phenomenon and causes postpartum thyroiditis.<xref ref-type="bibr" rid="article-30163.r15">[15]</xref><xref ref-type="bibr" rid="article-30163.r16">[16]</xref></p>
        <p>Drug-induced thyroiditis causing hyperthyroidism is usually caused by either an increase in the release and synthesis of thyroid hormone or by destructive thyroiditis caused by the release of preformed hormones. Whereas hypothyroidism is caused by a decrease in the synthesis and release of thyroid hormone or from hypophysitis causing secondary hypothyroidism. The iodine content of the drugs also causes thyroid dysfunction.</p>
        <p>Reidel&#x02019;s thyroiditis: Pathophysiology is not completely understood, but chronic inflammation by the mononuclear cells seems to play a role. It has also been claimed as IgG4 thyroid disease, which includes Reidel thyroiditis, autoimmune pancreatitis, interstitial pneumonia, and orbital pseudotumors.<xref ref-type="bibr" rid="article-30163.r12">[12]</xref></p>
      </sec>
      <sec id="article-30163.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Acute and Subacute Thyroiditis</bold>
</p>
        <p>Symptoms of upper respiratory tract infection could indicate subacute thyroiditis, and other infective symptoms like fever and neck pain could indicate acute infectious thyroiditis. History of recent radiation to the neck or radioactive iodine treatment could indicate radiation-induced thyroiditis.<xref ref-type="bibr" rid="article-30163.r17">[17]</xref></p>
        <p>On physical exam, most acute thyroiditis patients have a tender and inflamed thyroid gland.</p>
        <p>
<bold>Chronic Thyroiditis</bold>
</p>
        <p>For chronic thyroiditis, a detailed history is paramount to narrowing the etiology. Medication history is important to diagnose underlying drug-induced thyroiditis. Personal history and family history of autoimmune disease can help discover any increased risk of autoimmune thyroid disease.&#x000a0;Symptoms related to local compressive symptoms in the neck, including difficulty swallowing or choking sensation or hoarseness of the voice, could indicate underlying large goiter or large thyroid nodule or Riedel thyroiditis. Patients with Riedel thyroiditis usually present with dysphagia, odynophagia, respiratory distress due to the compression of the trachea, esophagus, and also because of the extension of the fibrosis.<xref ref-type="bibr" rid="article-30163.r18">[18]</xref></p>
        <p>Physical exam should include a detailed thyroid exam to evaluate any enlargement, tenderness on palpation, any abnormality in the texture, or any palpable nodules.</p>
        <p>Drug-induced thyroiditis can be clinically benign on the exam. Symptoms of hypothyroidism like weight gain, fatigue, constipation, dry skin in patients on amiodarone should raise the suspicion of drug-induced thyroiditis. Amiodarone can also cause hyperthyroidism, and clinical manifestations may be masked initially because amiodarone has beta-adrenergic blocking activity. Check-point inhibitor immunotherapy: Patients usually present with vague symptoms of hypothyroidism like fatigue, weight gain. It should be distinguished from secondary hypothyroidism as these drugs also cause hypophysitis.<xref ref-type="bibr" rid="article-30163.r19">[19]</xref></p>
        <p>Autoimmune thyroiditis and Hashimoto thyroiditis usually present with a painless goiter.</p>
        <p>Postpartum thyroiditis usually presents with symptoms of thyrotoxicosis like tachycardia, nervousness, and diarrhea with a history of recent childbirth.<xref ref-type="bibr" rid="article-30163.r20">[20]</xref></p>
        <p>Patients with Riedel thyroiditis can have a fixed, hard, painless goiter on physical exam. Most of the patients are euthyroid but can develop hypothyroidism.<xref ref-type="bibr" rid="article-30163.r18">[18]</xref></p>
      </sec>
      <sec id="article-30163.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Thyroid-stimulating hormone (TSH) should be checked to see if the patient has hyperthyroidism or hypothyroidism. Thyroid microsomal antibodies and thyroid receptor antibodies can be checked for confirmation of autoimmune thyroid disease. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are significantly elevated in infectious thyroiditis (bacterial).<xref ref-type="bibr" rid="article-30163.r2">[2]</xref></p>
        <p>Thyroid ultrasound is the most important and most commonly used imaging modality for evaluation of the thyroid gland.&#x000a0;Heterogenous thyroid parenchyma indicates inflammation of the thyroid gland, but it does not differentiate between production versus destruction thyroiditis. Thyroid ultrasound can also detect nodules in the thyroid gland. The characteristics of nodules can help to differentiate between benign or malignant nodules.</p>
        <p>A thyroid uptake and scan can be done to differentiate production thyroiditis or destruction thyroiditis in patients who present with thyrotoxicosis characterized by low TSH with or without elevated T4 and T3. Low uptake on thyroid scan would indicate destruction thyroiditis (Hashimoto thyroiditis, infectious thyroiditis),&#x000a0;while increased or normal uptake indicates production thyroiditis (Graves disease).<xref ref-type="bibr" rid="article-30163.r14">[14]</xref> A thyroid scan can help to further differentiate production thyroiditis into Graves disease, which will show increased uptake throughout the thyroid gland or toxic adenoma, which will show increased uptake in the nodule (hot nodule) with suppression of rest of the thyroid gland.</p>
        <p>Fine-needle aspiration is done to evaluate suspicious thyroid nodules to rule out malignancy. In general, any thyroid nodule, which is less than 10 mm, can be monitored without fine-needle aspiration.</p>
        <p>
<bold>Acute Thyroiditis&#x000a0;</bold>
</p>
        <p>Thyroid ultrasound, blood cultures, fine needle aspiration with gram stain should be obtained when the clinical presentation is suspicious of infectious thyroiditis. Thyroid function tests are usually normal, but in rare cases, hypo or hyperthyroidism may be present. In cases of radiation thyroiditis, there is a preceding history of radiation exposure or treatment with radioactive iodine for likely Graves disease, which will guide in the diagnosis.&#x000a0;</p>
        <p>
<bold>Subacute Thyroiditis</bold>
</p>
        <p>There is a strong association with HLA-35. ESR and CRP are markedly elevated, and so is leucocyte count. T4, T3, and TSH can vary depending on the hyperthyroid or hypothyroid phase. The iodine uptake is low, distinguishing the thyrotoxic phase from Graves disease.<xref ref-type="bibr" rid="article-30163.r21">[21]</xref></p>
        <p>
<bold>Chronic Thyroiditis&#x000a0;</bold>
</p>
        <p>Diagnostic tests for autoimmune/Hashimoto thyroiditis include thyroid peroxidase antibody, which is present in 90% of the patients and thyroglobulin antibody, which is present in 20% to 50%. Thyroid function tests show a hypothyroid picture with high TSH and low T3 and T4. It is associated with HLA-DR3, HLA-DR4, HLA-DR5 in Whites.<xref ref-type="bibr" rid="article-30163.r14">[14]</xref><xref ref-type="bibr" rid="article-30163.r21">[21]</xref></p>
        <p>In patients who are on drugs like amiodarone, lithium, interferon, interleukin 2, and checkpoint inhibitors should have baseline TSH at the commencement of treatment.<xref ref-type="bibr" rid="article-30163.r19">[19]</xref><xref ref-type="bibr" rid="article-30163.r22">[22]</xref> TSH, free T4, free T3 should be obtained in case of the development of symptoms of thyroid dysfunction. Thyroid ultrasound with an iodine uptake scan can be obtained to distinguish drug-induced destructive inflammatory thyroiditis from Graves disease. Uptake is low in drug-induced inflammatory thyroiditis and high in Graves disease.&#x000a0;</p>
        <p>Postpartum thyroiditis presents with symptoms of hyperthyroidism and history of recent pregnancy and should be evaluated with TSH, free T4, free T3. It can be distinguished from Graves disease by 24-hour iodine uptake scan, and the uptake is low in postpartum thyroiditis.<xref ref-type="bibr" rid="article-30163.r20">[20]</xref></p>
        <p>Riedel thyroiditis: Biopsy is necessary for definitive diagnosis. FNA may not be sufficient for diagnosis and may require an open biopsy for definitive diagnosis of this disease.<xref ref-type="bibr" rid="article-30163.r23">[23]</xref><xref ref-type="bibr" rid="article-30163.r18">[18]</xref></p>
      </sec>
      <sec id="article-30163.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Acute Thyroiditis</bold>
</p>
        <p>Infectious thyroiditis: Patients with suppurative thyroiditis can be managed with nonsurgical management.&#x000a0;Antibiotics are used to control infection. NSAIDs are used to control severe neck pain and inflammation. Surgical intervention, like abscess drainage, can be done if clinically indicated.<xref ref-type="bibr" rid="article-30163.r2">[2]</xref></p>
        <p>Radiation-induced thyroiditis: Treatment is symptomatic with NSAIDs or prednisone in severe cases. These patients are increased risk of hypothyroidism and should be followed with a thyroid function test.<xref ref-type="bibr" rid="article-30163.r24">[24]</xref></p>
        <p>
<bold>Subacute Thyroiditis</bold>
</p>
        <p>It is usually self-limiting, and symptomatic management is all that is needed. NSAIDs are preferred for pain control. In case of severe pain and severe symptoms of thyrotoxicosis, corticosteroids, and beta-blockers can be used for the treatment of inflammation and tachycardia due to thyrotoxicosis. The hypothyroid phase is usually mild and does not require treatment.<xref ref-type="bibr" rid="article-30163.r25">[25]</xref></p>
        <p>
<bold>Chronic Thyroiditis</bold>
</p>
        <p>Autoimmune thyroiditis: Hashimoto thyroiditis with normal thyroid function can be monitored without treatment with levothyroxine.<xref ref-type="bibr" rid="article-30163.r14">[14]</xref> Hyperthyroidism or Graves disease can be treated with methimazole or propylthiouracil. Methimazole is the drug of choice, but propylthiouracil is preferred during the first trimester of pregnancy and for treatment of the thyroid storm. Permanent treatment of Graves disease included radioactive iodine treatment and thyroidectomy.<xref ref-type="bibr" rid="article-30163.r26">[26]</xref></p>
        <p>Postpartum thyroiditis: It is usually transient, and 80% of patients eventually become euthyroid. Hypothyroid patients can be treated with levothyroxine and monitored with regular thyroid function.<xref ref-type="bibr" rid="article-30163.r20">[20]</xref></p>
        <p>Amiodarone induced thyroiditis: It can cause both hypothyroidism and hyperthyroidism.<xref ref-type="bibr" rid="article-30163.r27">[27]</xref></p>
        <p>Hypothyroidism- Once diagnosed, amiodarone is usually continued along with levothyroxine replacement. If amiodarone is stopped for a different reason, individuals without previous thyroid dysfunction usually progress to euthyroid state with the withdrawal of amiodarone.<xref ref-type="bibr" rid="article-30163.r27">[27]</xref></p>
        <p>Hyperthyroidism - Treatment of type I hyperthyroidism is done with beta-blockers and methimazole. For type 2 thyroiditis, the use of glucocorticoids is recommended to alleviate the hyperthyroid symptoms.</p>
        <p>Lithium: Treatment is to continue lithium and start treatment with levothyroxine. It can also cause hyperthyroidism and Graves disease secondary to goiter formation.<xref ref-type="bibr" rid="article-30163.r11">[11]</xref></p>
        <p>Riedel thyroiditis: Treatment is surgical.<xref ref-type="bibr" rid="article-30163.r23">[23]</xref></p>
      </sec>
      <sec id="article-30163.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of symptomatic thyroiditis includes acute hemorrhage into thyroid cyst, thyroid nodule, thyroid cancer, tonsillitis, and acute pharyngitis.</p>
      </sec>
      <sec id="article-30163.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Thyroiditis with or without thyroid dysfunction has a good prognosis, but long-standing hypothyroidism can predispose to myxedema come, which is more common in the elderly population and has a high mortality rate. Many patients with hypothyroid may have ongoing symptoms even with treatment, which may affect the quality of life.</p>
      </sec>
      <sec id="article-30163.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Myxedema coma: It is a medical emergency and is characterized by severe hypothyroidism with clinical features of hypothermia, hyponatremia, bradycardia. It is mostly seen in older patients. Treatment should be initiated on clinical suspicion without awaiting lab results. Steroids are given first followed by thyroxine replacement to prevent an adrenal crisis in the scenario of underlying adrenal insufficiency.<xref ref-type="bibr" rid="article-30163.r28">[28]</xref><xref ref-type="bibr" rid="article-30163.r29">[29]</xref></p>
        <p>Thyroid storm is a life-threatening endocrine emergency often triggered by a metabolically stressful event in a patient with long-standing hyperthyroidism like Graves disease. It can present with hyperpyrexia, tachycardia, agitation, and psychosis with laboratory evidence of low TSH, high free T4, and T3. Prompt recognition and treatment of the condition are necessary as this condition is associated with high mortality. The Burch-Wartofsky diagnostic criteria can help with the timely detection of thyroid storm.<xref ref-type="bibr" rid="article-30163.r30">[30]</xref>&#x000a0;The standard of care is immediate initiation of beta-blockers, thionamides, and glucocorticoids. Additionally, iodine and cholestyramine can also be used.<xref ref-type="bibr" rid="article-30163.r31">[31]</xref></p>
        <p>Infectious thyroiditis can lead to an abscess and septicemia if not treated promptly.<xref ref-type="bibr" rid="article-30163.r2">[2]</xref></p>
        <p>Patients with Hashimoto thyroiditis are at risk of developing thyroid lymphoma and carcinoma; thus, a rapidly progressing thyroid nodule enlargement or development of new nodules should raise the suspicion.</p>
      </sec>
      <sec id="article-30163.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Thyroiditis is a condition that occurs when the thyroid gland gets inflamed. The thyroid gland is responsible for making a hormone called thyroxine, which controls the human body's metabolism and energy utilization. When the gland is inflamed, due to any cause, it could make&#x000a0;insufficient or excessive hormone, which causes symptoms like fatigue, weight gain, depression or palpitations, weight loss, and anxiety, to name a few.</p>
        <p>Consult with your doctor to discuss the right treatment as the management varies depending on the type of thyroiditis, and the physician needs to investigate and follow up with laboratory tests to ensure continued management of the thyroiditis.</p>
      </sec>
      <sec id="article-30163.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Thyroiditis comprises of a group of diseases that can present with strikingly similar symptoms. This frequently poses a diagnostic dilemma to uncover the exact etiology. These patients may present with hyper or hypothyroid symptoms with subtle differences depending on the etiology. A thorough history and physical examination is the key to uncover these subtle differences. It is also important to consult with an endocrinologist to investigate the exact etiology of thyroiditis as well as to help institute the correct treatment and reduce patient morbidity.</p>
        <p>The current guidelines for management have been developed with expert recommendations and literature from peer-reviewed journals to determine the appropriateness of laboratory testing and imaging, as well as the formulation of and treatment strategies.</p>
      </sec>
      <sec id="article-30163.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30163">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/thyroiditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30163">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30163/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30163">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30163.s15">
        <fig id="article-30163.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Hashimoto Thyroiditis Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30163.s16">
        <title>References</title>
        <ref id="article-30163.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hollowell</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Staehling</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Flanders</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hannon</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Gunter</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>489</fpage>
            <page-range>489-99</page-range>
            <pub-id pub-id-type="pmid">11836274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paes</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McHenry</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Shoham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kloos</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Acute bacterial suppurative thyroiditis: a clinical review and expert opinion.</article-title>
            <source>Thyroid</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-55</page-range>
            <pub-id pub-id-type="pmid">20144025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Volp&#x000e9;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Row</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Ezrin</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Circulating viral and thyroid antibodies in subacute thyroiditis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1967</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>1275</fpage>
            <page-range>1275-84</page-range>
            <pub-id pub-id-type="pmid">4292248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohsako</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sudo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mukuta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sasazuki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>80</volume>
            <issue>12</issue>
            <fpage>3653</fpage>
            <page-range>3653-6</page-range>
            <pub-id pub-id-type="pmid">8530615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tandon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weetman</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>HLA associations with Hashimoto's thyroiditis.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1991</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>383</fpage>
            <page-range>383-6</page-range>
            <pub-id pub-id-type="pmid">1676351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jenkins</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Penny</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Mijovic</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Franklyn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-5</page-range>
            <pub-id pub-id-type="pmid">1356664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vargas</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Briones-Urbina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gladman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Papsin</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Walfish</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>327</fpage>
            <page-range>327-33</page-range>
            <pub-id pub-id-type="pmid">3260599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pearce</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Farwell</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Thyroiditis.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Jun</month>
            <day>26</day>
            <volume>348</volume>
            <issue>26</issue>
            <fpage>2646</fpage>
            <page-range>2646-55</page-range>
            <pub-id pub-id-type="pmid">12826640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imaizumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pritsker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>TF</given-names>
              </name>
            </person-group>
            <article-title>Intrathyroidal fetal microchimerism in pregnancy and postpartum.</article-title>
            <source>Endocrinology</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>143</volume>
            <issue>1</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">11751616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garon-Czmil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petitpain</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rouby</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sassier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Babai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yelehe-Okouma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weryha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gillet</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance database.</article-title>
            <source>Fundam Clin Pharmacol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>241</fpage>
            <page-range>241-249</page-range>
            <pub-id pub-id-type="pmid">30308083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Association between lithium use and thyrotoxicosis caused by silent thyroiditis.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>501</fpage>
            <page-range>501-8</page-range>
            <pub-id pub-id-type="pmid">11678833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umehara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Masaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hamano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kamisawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimosegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimatsu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Notohara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sumida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mimori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mishima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hibi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsubouchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohara</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.</article-title>
            <source>Mod Rheumatol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-30</page-range>
            <pub-id pub-id-type="pmid">22218969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burikhanov</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Matsuzaki</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo.</article-title>
            <source>Thyroid</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-9</page-range>
            <pub-id pub-id-type="pmid">10718548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peng</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Huai-En Chang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pennant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Munir</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>A Literature Review of Painful Hashimoto Thyroiditis: 70 Published Cases in the Past 70 Years.</article-title>
            <source>J Endocr Soc</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>bvz008</fpage>
            <pub-id pub-id-type="pmid">32047869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keely</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Postpartum thyroiditis: an autoimmune thyroid disorder which predicts future thyroid health.</article-title>
            <source>Obstet Med</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">27579088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Groot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Abalovich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Amino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barbour</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cobin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Eastman</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Luton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mandel</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mestman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rovet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>8</issue>
            <fpage>2543</fpage>
            <page-range>2543-65</page-range>
            <pub-id pub-id-type="pmid">22869843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giuffrida</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bagnato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Campenn&#x000ec;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giovinazzo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Alibrandi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Trimarchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruggeri</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-94</page-range>
            <pub-id pub-id-type="pmid">31301020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fatourechi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>McIver</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sebo</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Fatourechi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008.</article-title>
            <source>Thyroid</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>765</fpage>
            <page-range>765-72</page-range>
            <pub-id pub-id-type="pmid">21568724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muller</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lecumberri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Decallonne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dayan</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy.</article-title>
            <source>Eur Thyroid J</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>173</fpage>
            <page-range>173-185</page-range>
            <pub-id pub-id-type="pmid">31602359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ide</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshioka</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kudo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishihara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyauchi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.</article-title>
            <source>Thyroid</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1027</fpage>
            <page-range>1027-31</page-range>
            <pub-id pub-id-type="pmid">24400892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruchala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Szczepanek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sowinski</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Sonoelastography in de Quervain thyroiditis.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-90</page-range>
            <pub-id pub-id-type="pmid">21296992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyer</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Cabanillas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Waguespack</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Thosani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lavis</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Busaidy</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Subudhi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Diab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dadu</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.</article-title>
            <source>Thyroid</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1243</fpage>
            <page-range>1243-1251</page-range>
            <pub-id pub-id-type="pmid">30132401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harigopal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sahoo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Recant</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>DeMay</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Fine-needle aspiration of Riedel's disease: report of a case and review of the literature.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <page-range>193-7</page-range>
            <pub-id pub-id-type="pmid">14986301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Radioiodine therapy versus antithyroid medications for Graves' disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Feb</month>
            <day>18</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD010094</fpage>
            <pub-id pub-id-type="pmid">26891370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samuels</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Subacute, silent, and postpartum thyroiditis.</article-title>
            <source>Med Clin North Am</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-33</page-range>
            <pub-id pub-id-type="pmid">22443972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Burch</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Greenlee</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Laurberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Rivkees</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Samuels</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <fpage>1343</fpage>
            <page-range>1343-1421</page-range>
            <pub-id pub-id-type="pmid">27521067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dullaart</surname>
                <given-names>RPF</given-names>
              </name>
              <name>
                <surname>Sluiter</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Rienstra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Gelder</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Links</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>The clinical value of regular thyroid function tests during amiodarone treatment.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>177</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-14</page-range>
            <pub-id pub-id-type="pmid">28424174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yasunaga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fushimi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan.</article-title>
            <source>J Epidemiol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>117</fpage>
            <page-range>117-122</page-range>
            <pub-id pub-id-type="pmid">28142035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popoveniuc</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mete</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A diagnostic scoring system for myxedema coma.</article-title>
            <source>Endocr Pract</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>808</fpage>
            <page-range>808-17</page-range>
            <pub-id pub-id-type="pmid">24518183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Idrose</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Acute and emergency care for thyrotoxicosis and thyroid storm.</article-title>
            <source>Acute Med Surg</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>147</fpage>
            <page-range>147-157</page-range>
            <pub-id pub-id-type="pmid">29123713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30163.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akamizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Isozaki</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wakino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iburi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuboi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Monden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kouki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Teramukai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uehara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <collab>Japan Thyroid Association</collab>
            </person-group>
            <article-title>Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.</article-title>
            <source>Thyroid</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>7</issue>
            <fpage>661</fpage>
            <page-range>661-79</page-range>
            <pub-id pub-id-type="pmid">22690898</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
